Home Cart Sign in  
Chemical Structure| 54-42-2 Chemical Structure| 54-42-2

Structure of Idoxuridine
CAS No.: 54-42-2

Chemical Structure| 54-42-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Idoxuridine is an analog of deoxyuridine that inhibits viral DNA synthesis.

Synonyms: 5-Iodo-2′-deoxyuridine; 5-IUdR; Idoxuridin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Idoxuridine

CAS No. :54-42-2
Formula : C9H11IN2O5
M.W : 354.10
SMILES Code : OC[C@@H]1[C@H](C[C@H](N2C(NC(C(I)=C2)=O)=O)O1)O
Synonyms :
5-Iodo-2′-deoxyuridine; 5-IUdR; Idoxuridin
MDL No. :MFCD00134656
InChI Key :XQFRJNBWHJMXHO-RRKCRQDMSA-N
Pubchem ID :5905

Safety of Idoxuridine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Nanog-GFP mESCs 10 μM 24 hours IdU treatment increased the Fano factor of Nanog protein expression by about threefold with little change in mean expression. Science. 2021 Aug 20;373(6557):eabc6506
mouse embryonic stem cells (mESCs) 10 μM 24 hours IdU treatment increased transcriptional noise with minimal effect on mean transcript levels. Science. 2021 Aug 20;373(6557):eabc6506
HCT116 cells 10 μM 20 minutes or 1 hour To evaluate the incorporation of IdU into cellular DNA, results showed that IdU had a higher signal intensity compared to BrdU. PLoS One. 2015 Jul 10;10(7):e0132393
HeLa cells 10 μM 20 minutes or 1 hour To evaluate the incorporation of IdU into cellular DNA, results showed that IdU had a higher signal intensity compared to BrdU. PLoS One. 2015 Jul 10;10(7):e0132393
Equine dermal fibroblasts (E. Derm) 33.75±15.85 µM (RTCA) and 7.49±1.00 µM (qPCR) 48 hours Evaluation of Idoxuridine's antiviral activity against EHV-4, showing weak inhibitory effects. Viruses. 2024 May 8;16(5):746
Mesoangioblasts (MABs) 25 μM 48 to 120 hours IdU promotes osteogenic differentiation of MABs while inhibiting myogenesis. IdU-induced osteogenesis does not rely on the BMP-2/SMADs pathway but activates the DDR (DNA Damage Response) pathway, including ATM and p38 activation, ultimately promoting RUNX2 phosphorylation. Sci Rep. 2019 Apr 1;9(1):5447

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02381561 Advanced Bile Duct Carcinoma ... More >> Stage II Esophageal Cancer AJCC v7 Stage II Pancreatic Cancer AJCC v6 and v7 Stage IIA Esophageal Cancer AJCC v7 Stage IIA Pancreatic Cancer AJCC v6 and v7 Stage IIB Esophageal Cancer AJCC v7 Stage IIB Pancreatic Cancer AJCC v6 and v7 Stage III Colon Cancer AJCC v7 Stage III Esophageal Cancer AJCC v7 Stage III Gastric Cancer AJCC v7 Stage III Liver Cancer Stage III Pancreatic Cancer AJCC v6 and v7 Stage III Rectal Cancer AJCC v7 Stage III Small Intestinal Cancer AJCC v7 Stage IIIA Colon Cancer AJCC v7 Stage IIIA Esophageal Cancer AJCC v7 Stage IIIA Gastric Cancer AJCC v7 Stage IIIA Rectal Cancer AJCC v7 Stage IIIA Small Intestinal Cancer AJCC v7 Stage IIIB Colon Cancer AJCC v7 Stage IIIB Esophageal Cancer AJCC v7 Stage IIIB Gastric Cancer AJCC v7 Stage IIIB Rectal Cancer AJCC v7 Stage IIIB Small Intestinal Cancer AJCC v7 Stage IIIC Colon Cancer AJCC v7 Stage IIIC Esophageal Cancer AJCC v7 Stage IIIC Gastric Cancer AJCC v7 Stage IIIC Rectal Cancer AJCC v7 Stage IV Colon Cancer AJCC v7 Stage IV Esophageal Cancer AJCC v7 Stage IV Gastric Cancer AJCC v7 Stage IV Liver Cancer Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IV Rectal Cancer AJCC v7 Stage IV Small Intestinal Cancer AJCC v7 Stage IVA Colon Cancer AJCC v7 Stage IVA Liver Cancer Stage IVA Rectal Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7 Stage IVB Liver Cancer Stage IVB Rectal Cancer AJCC v7 Less << Phase 1 Recruiting - United States, Rhode Island ... More >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Timothy J. Kinsella    401-444-8311    tkinsella@lifespan.org    Principal Investigator: Timothy J. Kinsella Less <<
NCT00159978 - Terminated(Problems with FMISO... More >> supply) Less << - Netherlands ... More >> UMC St Radboud, Department of Radiotherapy Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00003405 Leukemia Phase 2 Unknown - United States, Illinois ... More >> Cook County Hospital Chicago, Illinois, United States, 60612-9985 Rush Cancer Institute Chicago, Illinois, United States, 60612 Angelo P. Creticos, M.D. Cancer Center Chicago, Illinois, United States, 60657 Rush-Riverside Cancer Center Kankakee, Illinois, United States, 60901 Less <<
NCT00042250 Hematologic Malignancies Not Applicable Completed - United States, Texas ... More >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00109785 Breast Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03307772 Herpes Labialis Not Applicable Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.82mL

0.56mL

0.28mL

14.12mL

2.82mL

1.41mL

28.24mL

5.65mL

2.82mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories